Results 241 to 250 of about 484,445 (306)

A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial. [PDF]

open access: yesSignal Transduct Target Ther
Chu N   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy